Can We Use Terminalia Arjuna (Roxb.) Wight and Arn in Place of Novel Oral Anticoagulants (NOACs) in Post-COVID-19Cardiac Conditions?

Simple item page
dc.contributor.authorDwivedi, Sen_US
dc.contributor.authorSharma, Ven_US
dc.contributor.authorPatil, CR.en_US
dc.date.accessioned2023-06-17T07:12:09Z
dc.date.available2023-06-17T07:12:09Z
dc.date.issued2022-03
dc.identifier.affiliationsDepartment of Cardiology, National Heart Institute, Community Center, East of Kailash, New Delhi, Delhi, Indiaen_US
dc.identifier.affiliationsDepartment of Cardiology, National Heart Institute, Community Center, East of Kailash, New Delhi, Delhi, Indiaen_US
dc.identifier.affiliationsDepartment of Pharmacology, Delhi Pharmaceutical Sciences and Research University, Pushpvihar, New Delhi, India.en_US
dc.identifier.citationDwivedi S, Sharma V, Patil CR. . Can We Use Terminalia Arjuna (Roxb.) Wight and Arn in Place of Novel Oral Anticoagulants (NOACs) in Post-COVID-19Cardiac Conditions?. Journal of Pharmacology and Pharmacotherapeutics. 2022 Mar; 13(1): 95–96en_US
dc.identifier.issn0976-500X
dc.identifier.issn0976-5018
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/216039
dc.languageenen_US
dc.publisherSAGE Publicationsen_US
dc.relation.issuenumber1en_US
dc.relation.volume13en_US
dc.source.urihttps://doi.org/10.1177/0976500X221080202en_US
dc.titleCan We Use Terminalia Arjuna (Roxb.) Wight and Arn in Place of Novel Oral Anticoagulants (NOACs) in Post-COVID-19Cardiac Conditions?en_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
JPP2022v13n1p95.pdf
Size:
501.67 KB
Format:
Adobe Portable Document Format
Download
Collections
Journal of Pharmacology and Pharmacotherapeutics